Antiphospholipid Syndrome
75
23
23
25
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.0%
3 terminated out of 75 trials
89.3%
+2.7% vs benchmark
15%
11 trials in Phase 3/4
12%
3 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 25 completed trials
Clinical Trials (75)
Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research
Hematological Markers MPV, PLR, and NLR in Primary Versus Secondary Antiphospholipid Syndrome
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device
Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome
Prevalence and Etiologies of Intracranial Stenosis in Patients With Antiphospholipid Syndrome
RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome
International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants
Point of Care Testing INR in Antiphospholipid Syndrome
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Pregnancy and Medically Assisted Conception in Rare Diseases
An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
A Study to Evaluate Crovalimab in People With Antiphospholipid Syndrome (APS)
Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases
Rheumatology Patient Registry and Biorepository
Medium-term Follow-up of Patients With Obstetric Antiphospholipid Syndrome: MRI Study of White Matter
Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases
Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases
A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases
Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS